$166.89
-0.68-0.41%
Last update: Nov 6, 4:29 PM
Gilead Sciences Inc
GILDNASDAQ
Gilead Sciences (GILD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $2.55 | $2.18 | 17.0 % |
| Q2 | Aug 4, 2026 | $-6.75 | $-7.14 | 5.46 % |
| Q1 | May 7, 2026 | $2.03 | $1.91 | 6.28 % |
| Q4 | Feb 10, 2026 | $1.86 | $1.83 | 1.64 % |
Quarterly Revenue (Billions)
Gilead Sciences (GILD) last issued guidance on October 29, 2026 for fiscal year 2026. The company guided earnings per share in the range of $-1.2 - $-0.85, compared to a consensus EPS estimate of $-0.47. Gilead Sciences also guided revenue in the range of $31B - $31.3B for the period.
Compared to prior guidance, Gilead Sciences lowered its EPS outlook from a previous range of $-0.65 - $-0.3. On the revenue side, the company raised its revenue forecast from a prior range of $30.1B - $30.4B.
Gilead Sciences has issued 16 guidance updates between February 2, 2023 and October 29, 2026. During this period, the company raised its outlook 8 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.18 | $-7.14 | $1.91 | $1.83 |
| Actual | $2.55 | $-6.75 | $2.03 | $1.86 |
| Surprise | +17.0% | +5.46% | +6.28% | +1.64% |
| Revenue | ||||
| Estimate | $7.81B | $7.40B | $6.92B | $7.64B |
| Actual | $8.30B | $7.80B | $6.96B | $7.92B |
| Surprise | +6.34% | +5.42% | +0.61% | +3.80% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.15 | $2.17 | $2.30 | $2.54 |
| Revenue | ||||
| Consensus | $8.31B | $7.42B | — | — |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $8.30B | $7.81B | 6.34 % |
| Q2 | Aug 4, 2026 | $7.80B | $7.40B | 5.42 % |
| Q1 | May 7, 2026 | $6.96B | $6.92B | 0.61 % |
| Q4 | Feb 10, 2026 | $7.93B | $7.64B | 3.80 % |
